Funding for this research was provided by:
Received: 9 October 2018
Accepted: 11 March 2019
First Online: 2 April 2019
Ethics approval and consent to participate
: No ethics approval was necessary for this study as only peer-reviewed published data were used.
: Not applicable.
: Rafael Torrejon Torres is an employee of Coreva Scientific GmbH & Co KG, which received consultancy fees from Cardinal Health, the manufacturer of the Kendall IPC device, for performing, analysing, and communicating the work presented here. Rhodri Saunders is the owner of Coreva Scientific GmbH & Co KG. Dr. Ho was previously a Global DVT advisor to Medtronic, a former manufacturer of IPC devices.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.